Literature DB >> 23968609

Chikungunya virus infection, Brazzaville, Republic of Congo, 2011.

Jean-Vivien Mombouli, Patrick Bitsindou, Darrel O A Elion, Allen Grolla, Heinz Feldmann, Fabien R Niama, Henri-Joseph Parra, Vincent J Munster.   

Abstract

Entities:  

Keywords:  Aedes aegypti; Aedes albopictus; Brazzaville; Republic of Congo; chikungunya virus; mosquitoes; outbreaks; viruses

Mesh:

Year:  2013        PMID: 23968609      PMCID: PMC3810930          DOI: 10.3201/eid1909.130451

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Chikungunya virus (CHIKV) is a positive single-stranded RNA virus within the genus Alphavirus, family Togaviridae (–). In humans, CHIKV infection has a rapid onset and is typically cleared in 5–7 days. Following transmission, CHIKV replicates in the skin and then disseminates to the liver and joints. The incubation period for CHIKV infection is 2–4 days. Signs and symptoms of infection include high fever, rigors, headache, photophobia, and a petechial or maculopapular rash, and most infected persons also report severe joint pain (–). CHIKV is transmitted through the bite of infected Aedes aegypti and Ae. albopictus mosquitoes. The current reemergence of CHIKV seems to be related to 1) CHIKV host switching from Ae. aegypti to Ae. albopictus mosquitoes, while retaining Ae. aegypti mosquitoes as a vector, and 2) introduction of Ae. albopictus mosquitoes, which were originally from Southeast Asia, into new areas of the world, including Africa. Severe epidemics of CHIKV infection have occurred in countries in the Indian Ocean region and Africa (–). We report an outbreak of CHIKV infection in Brazzaville, Republic of Congo, that was associated with the mosquito vectors Ae. albopictus and Ae. aegypti. In June 2011, reports were received of an outbreak of a new drug-resistant form of malaria in southwest Brazzaville. Diagnostic capacity for detecting arboviruses, including CHIKV, by using molecular diagnostic assays was immediately implemented at the Laboratoire National de Santé Publique in Brazzaville. Blood samples were collected from 23 suspected case-patients, and serum samples were obtained and stored at 4°C. RNA from patients’ serum samples was extracted by using the QIAamp Viral RNA Kit (QIAGEN, Valencia, CA, USA) according to the manufacturer’s instructions. To determine if CHIKV, yellow fever virus, dengue virus, or malarial parasites were present in the serum samples, we performed quantitative reverse transcription PCR with Lightcycler 480 RNA Master Hydrolysis Probes (Roche Diagnostics, Mannheim, Germany) on the SmartCycler platform (Cepheid, Sunnyvale, CA, USA) (–). A cycle threshold (Ct) cutoff value of <40 was considered positive. Primary testing focused on CHIKV, and genomic RNA was detected in 21 of 23 patient serum samples (Ct 17.55–37.91) (Table). Neither yellow fever nor dengue virus genomic RNA was detected in any patient samples. However, malaria parasite genetic material was detected in the 2 samples that were negative for CHIKV (Table).
Table

Detection of virus genomic RNA in patient serum samples, Brazzaville, Republic of Congo, June 2011*

Patient sample IDVirus, Ct
Malaria Ct
ChikungunyaYellow feverDengue
1†25.62>40>40>40
2>40>40>4032.33
317.55>40>40>40
437.91>40>40>40
521.36>40>40>40
621.00>40>40>40
720.26>40>40>40
819.78>40>40>40
9>40>40>4033.71
1025.77>40>40>40
11‡21.20>40>40>40
1222.98>40>40>40
1329.97>40>40>40
1423.50>40>40>40
15§31.97>40>40>40
1631.44>40>40>40
1733.54>40>40>40
1831.83>40>40>40
1934.63>40>40>40
2034.90>40>40>40
2133.46>40>40>40
2229.18>40>40>40
2333.16>40>40>40

*Except as otherwise indicated, all samples were collected on June 27, 2011. ID, identification; A Ct cutoff value of <40 was considered positive. Ct, cycle threshold.
†Collected on June 23, 2011.
‡Collected on June 24, 2011.
§Collected on June 27, 2011.

*Except as otherwise indicated, all samples were collected on June 27, 2011. ID, identification; A Ct cutoff value of <40 was considered positive. Ct, cycle threshold.
†Collected on June 23, 2011.
‡Collected on June 24, 2011.
§Collected on June 27, 2011. To investigate the involvement and distribution of potential vector mosquito species, we initiated an entomological study in the Makélékélé and Mfilou districts of Brazzaville, the 2 areas associated with the CHIKV outbreak. Mosquitoes were collected at various places in the 2 districts during different hours of the day (Technical Appendix Table). Mosquitoes were separated by species, Ae. aegypti or Ae. albopictus, into 13 different pools. The pools were homogenized in lysis buffer (Buffer AVL; QIAGEN) by using sterile disposable tissue grinders, and RNA was extracted. We then analyzed the samples for the presence of CHIKV genomic RNA by following the procedures described above for the serum samples. All 13 mosquito pools were positive for CHIKV genomic RNA (Ct 23.5–34.63) (Technical Appendix Table). Our study in Brazzaville identified CHIKV as the causative agent for the 2011 outbreak of febrile illness characterized by severe joint pain. In the affected Brazzaville communities, the illness had been named robot malaria because of its effects on posture and locomotion, effects that are typical of CHIKV infection. We also found that during the outbreak, CHIKV was present in Ae. aegypti and Ae. albopictus mosquitoes, suggesting that these mosquitoes played a role in dissemination and spread of the virus. These findings are in line with the increasing distribution of CHIKV and its vector, Ae. albopictus mosquitoes, in Africa. Of note, the outbreak in the Republic of Congo seems to have been associated with Ae. aegypti and Ae. albopictus mosquitoes, whereas outbreaks of CHIKV infection in neighboring Gabon are predominantly associated with Ae. albopictus mosquitoes (,). Our study confirms the suspected presence of Ae. albopictus mosquitoes in the Republic of Congo. The identification of Ae. albopictus mosquitoes as a vector for CHIKV in remote areas in Gabon indicates that similar remote areas in the Republic of Congo could also be at risk during future outbreaks of CHIKV infection (). The availability of diagnostic capacity for arbovirus detection in sub-Saharan Africa is urgently needed for the deployment of potential intervention strategies. Improved surveillance and rapid identification of novel arbovirus–associated outbreaks would strengthen the potential for recognition of arbovirus-related diseases by health care providers and public health officials. In the absence of CHIKV-specific prophylactic or therapeutic control measures, the only current mitigation strategies are based on community outreach, which provides early alerts regarding outbreaks, and on control of the mosquito vectors ().

Technical Appendix

Detection of virus genomic RNA in mosquito pools, Brazzaville, Republic of Congo, June 2011*
  10 in total

1.  A chikungunya outbreak associated with the vector Aedes albopictus in remote villages of Gabon.

Authors:  Christophe Paupy; Fabrice Kassa Kassa; Mélanie Caron; Dieudonné Nkoghé; Eric M Leroy
Journal:  Vector Borne Zoonotic Dis       Date:  2011-12-05       Impact factor: 2.133

Review 2.  Chikungunya: a re-emerging virus.

Authors:  Felicity J Burt; Micheal S Rolph; Nestor E Rulli; Suresh Mahalingam; Mark T Heise
Journal:  Lancet       Date:  2011-11-17       Impact factor: 79.321

3.  Real-time fluorescence-based PCR for detection of malaria parasites.

Authors:  May-Ann Lee; Chiew-Hoon Tan; Lay-Tin Aw; Choon-Siang Tang; Mulkit Singh; Sze-Hee Lee; Hwee-Pin Chia; Eric P H Yap
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

Review 4.  Biology and pathogenesis of chikungunya virus.

Authors:  Olivier Schwartz; Matthew L Albert
Journal:  Nat Rev Microbiol       Date:  2010-07       Impact factor: 60.633

5.  Recent introduction and rapid dissemination of Chikungunya virus and Dengue virus serotype 2 associated with human and mosquito coinfections in Gabon, central Africa.

Authors:  Mélanie Caron; Christophe Paupy; Gilda Grard; Pierre Becquart; Illich Mombo; Branly Bikie Bi Nso; Fabrice Kassa Kassa; Dieudonné Nkoghe; Eric Maurice Leroy
Journal:  Clin Infect Dis       Date:  2012-06-05       Impact factor: 9.079

6.  Development of field-based real-time reverse transcription-polymerase chain reaction assays for detection of Chikungunya and O'nyong-nyong viruses in mosquitoes.

Authors:  Darci R Smith; John S Lee; Jordan Jahrling; David A Kulesh; Michael J Turell; Jennifer L Groebner; Monica L O'Guinn
Journal:  Am J Trop Med Hyg       Date:  2009-10       Impact factor: 2.345

7.  Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR.

Authors:  Christian Drosten; Stephan Göttig; Stefan Schilling; Marcel Asper; Marcus Panning; Herbert Schmitz; Stephan Günther
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

Review 8.  Arthritogenic alphaviruses--an overview.

Authors:  Andreas Suhrbier; Marie-Christine Jaffar-Bandjee; Philippe Gasque
Journal:  Nat Rev Rheumatol       Date:  2012-05-08       Impact factor: 20.543

9.  Insecticide susceptibility of Aedes aegypti and Aedes albopictus in Central Africa.

Authors:  Basile Kamgang; Sébastien Marcombe; Fabrice Chandre; Elysée Nchoutpouen; Philippe Nwane; Josiane Etang; Vincent Corbel; Christophe Paupy
Journal:  Parasit Vectors       Date:  2011-05-15       Impact factor: 3.876

10.  Clinical forms of chikungunya in Gabon, 2010.

Authors:  Dieudonné Nkoghe; Roland Fabrice Kassa; Mélanie Caron; Gilda Grard; Illich Mombo; Branly Bikié; Christophe Paupy; Pierre Becquart; Ulrich Bisvigou; Eric Maurice Leroy
Journal:  PLoS Negl Trop Dis       Date:  2012-02-14
  10 in total
  15 in total

Review 1.  Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies.

Authors:  Laurie A Silva; Terence S Dermody
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

2.  Chikungunya fever in Africa: a systematic review.

Authors:  Gianluca Russo; Lorenzo Subissi; Giovanni Rezza
Journal:  Pathog Glob Health       Date:  2020-04-18       Impact factor: 2.894

3.  First record of Aedes albopictus in inland Africa along the River Niger in Bamako and Mopti, Mali.

Authors:  Günter C Müller; Onie Tsabari; Mohamed M Traore; Sekou F Traore; Seydou Doumbia; Vasiliy D Kravchenko; Amy Junnila; John C Beier
Journal:  Acta Trop       Date:  2016-07-19       Impact factor: 3.112

4.  Distribution of Aedes mosquitoes in the Kilimanjaro Region of northern Tanzania.

Authors:  Julian T Hertz; Lucille J Lyaruu; Eng Eong Ooi; Franklin W Mosha; John A Crump
Journal:  Pathog Glob Health       Date:  2016-05       Impact factor: 2.894

5.  A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.

Authors:  Laurie A Silva; Solomiia Khomandiak; Alison W Ashbrook; Romy Weller; Mark T Heise; Thomas E Morrison; Terence S Dermody
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

6.  First reported chikungunya fever outbreak in the republic of Congo, 2011.

Authors:  Nanikaly Moyen; Simon-Djamel Thiberville; Boris Pastorino; Antoine Nougairede; Laurence Thirion; Jean-Vivien Mombouli; Yannick Dimi; Isabelle Leparc-Goffart; Maria Rosaria Capobianchi; Amelia Dzia Lepfoundzou; Xavier de Lamballerie
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

Review 7.  Invasion of Aedes albopictus (Diptera: Culicidae) into central Africa: what consequences for emerging diseases?

Authors:  Carine Ngoagouni; Basile Kamgang; Emmanuel Nakouné; Chistophe Paupy; Mirdad Kazanji
Journal:  Parasit Vectors       Date:  2015-03-31       Impact factor: 3.876

Review 8.  Chikungunya virus-vector interactions.

Authors:  Lark L Coffey; Anna-Bella Failloux; Scott C Weaver
Journal:  Viruses       Date:  2014-11-24       Impact factor: 5.048

9.  Susceptibility profile and metabolic mechanisms involved in Aedes aegypti and Aedes albopictus resistant to DDT and deltamethrin in the Central African Republic.

Authors:  Carine Ngoagouni; Basile Kamgang; Cécile Brengues; Gildas Yahouedo; Christophe Paupy; Emmanuel Nakouné; Mirdad Kazanji; Fabrice Chandre
Journal:  Parasit Vectors       Date:  2016-11-24       Impact factor: 3.876

10.  Importance of mosquito "quasispecies" in selecting an epidemic arthropod-borne virus.

Authors:  Marie Vazeille; Karima Zouache; Anubis Vega-Rúa; Jean-Michel Thiberge; Valérie Caro; André Yébakima; Laurence Mousson; Géraldine Piorkowski; Catherine Dauga; Marie-Christine Vaney; Mosè Manni; Giuliano Gasperi; Xavier de Lamballerie; Anna-Bella Failloux
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.